Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice

References

• Wolf-MaierKCooperRSBanegasJRHypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United StatesJAMA2003289182363236912746359
   PubMed Web of Science ®Google Scholar
• KearneyPMWheltonMReynoldsKWheltonPKHeJWorldwide prevalence of hypertension: a systematic reviewJ Hypertens2004221111915106785
   PubMed Web of Science ®Google Scholar
• LewingtonSClarkeRQizilbashNPetoRCollinsRAge-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesLancet200236093491903191312493255
   PubMed Web of Science ®Google Scholar
• Leitlinien zur Behandlung der arteriellen Hypertonie 2008. Deutsche Hochdruckliga, 2008.
   Google Scholar
• ManciaGDe BackerGDominiczakAGuidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20072561105118717563527
   PubMed Web of Science ®Google Scholar
• BobrieGDeloncaJMoulinCGiacominoAPostel-VinayNAsmarRA home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinationsAm J Hypertens200518111482148816280286
   PubMed Web of Science ®Google Scholar
• Kassler-TaubKLittlejohnTElliottWRuddyTAdlerEComparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study InvestigatorsAm J Hypertens199811(4 Pt 1)4454539607383
   PubMed Web of Science ®Google Scholar
• ManciaGKorliparaKvan RossumPVillaGSilvertBAn ambulatory blood pressure monitoring study of the comparative antihypertensive efficacy of two angiotensin II receptor antagonists, irbesartan and valsartanBlood Press Monit20027213514212048432
   PubMed Web of Science ®Google Scholar
• KocharMGuthrieRTriscariJKassler-TaubKReevesRAMatrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertensionAm J Hypertens199912(8 Pt 1):79780510480473
   PubMed Web of Science ®Google Scholar
• NeutelJMFranklinSSOparilSBhaumikAPtaszynskaALapuertaPEfficacy and safety of irbesartan/HCTZ combination therapy as initial treatment for rapid control of severe hypertensionJ Clin Hypertens (Greenwich)200681285085717170610
   PubMedGoogle Scholar
• OparilSGuthrieRLewinAJAn elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study InvestigatorsClin Ther19982033984099663357
   PubMed Web of Science ®Google Scholar
• BobrieGDeloncaJMoulinCGiacominoAPostel-VinayNAsmarRA home blood pressure monitoring study comparing the antihyperten-sive efficacy of two angiotensin II receptor antagonist fixed combinationsAm J Hypertens200518111482148816280286
   PubMed Web of Science ®Google Scholar
• NeutelJMSmithDAmbulatory blood pressure comparison of the anti-hypertensive efficacy of fixed combinations of irbesartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild-to-moderate hypertensionJ Int Med Res200533662063116372579
   PubMed Web of Science ®Google Scholar
• ForsterASmolkaWJungCBestehornK[Fixed-combination of losartan/hydrochlorothiazide 100 mg/25 mg. Tolerability and efficacy on blood pressure measured in the practice and for 24 hours]MMW Fortschritte der Medizin2007149Suppl 311111817955788
   PubMedGoogle Scholar
• BramlagePFixed combination of irbesartan and hydrochlorothia-zide in the management of hypertensionVasc Health Risk Manag2009521322419436667
   PubMedGoogle Scholar
• SchuhlenHAbtsMKastratiD[Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study]Herz200732541942517687532
   PubMed Web of Science ®Google Scholar
• SchraderJBramlagePLudersSThoenesMSchirmerAPaarDWBP goal achievement in patients with uncontrolled hypertension: results of the treat-to-target post-marketing survey with irbesartanClin Drug Investig20072711783796
   PubMed Web of Science ®Google Scholar
• FranklinSLapuertaPCoxDDonovanMInitial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapyJ Clin Hypertens (Greenwich)2007912 Suppl 5152218046108
   PubMedGoogle Scholar
• SchmiederREKreklerM[Observational study of blood pressure control and microalbuminuria in type 2 diabetics on irbesartan or irbesartan/HCTZ]MMW Fortschr Med2005147Suppl 39710116261944
   PubMedGoogle Scholar
• SaundersECableGNeutelJPredictors of blood pressure response to angiotensin receptor blocker/diuretic combination therapy: a secondary analysis of the irbesartan/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) studyJ Clin Hypertens (Greenwich)2008101273318174768
   PubMed Web of Science ®Google Scholar
• SowersJRNeutelJMSaundersEAntihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetesJ Clin Hypertens (Greenwich)20068747048016849900
   PubMedGoogle Scholar
• CushmanWCNeutelJMSaundersEEfficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapyAm J Geriatr Cardiol2008171273618174757
   PubMedGoogle Scholar
• WeirMRNeutelJMBhaumikADe ObaldiaMELapuertaPThe efficacy and safety of initial use of irbesartan/hydrochlorothiazide fixed-dose combination in hypertensive patients with and without high cardiovascular riskJ Clin Hypertens (Greenwich)2007912 Suppl 5233018046109
   PubMedGoogle Scholar
• NeutelJMFranklinSSLapuertaPBhaumikAPtaszynskaAA comparison of the efficacy and safety of irbesartan/HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertensionJ Hum Hypertens200822426627417928878
   PubMed Web of Science ®Google Scholar